Cancer Center at Rutgers

Cancer Center at Rutgers
Name	Cancer Center at Rutgers
Established	1974
Type	Academic cancer center
Affiliation	Rutgers, The State University of New Jersey
Location	New Brunswick, Newark, Piscataway, New Jersey, United States

Cancer Center at Rutgers is an academic and clinical oncology enterprise affiliated with Rutgers, The State University of New Jersey that integrates research, patient care, education, and community outreach across multiple campuses. Founded through the consolidation of legacy programs and federally funded initiatives, the center collaborates with medical schools, hospitals, and research institutes to translate discoveries in molecular oncology, clinical trials, and population science into treatments. Its mission aligns with national and state initiatives involving translational medicine, precision oncology, and health disparities research.

History

The center traces origins to early cancer research activities at Rutgers University and affiliated hospitals following initiatives by the National Cancer Institute and state health authorities in the 1970s. Growth accelerated through partnerships with University of Medicine and Dentistry of New Jersey and later reorganization during the creation of Rutgers Biomedical and Health Sciences and the integration of faculty from Robert Wood Johnson Medical School and Rutgers School of Dental Medicine. Major milestones include designation efforts linked to NCI competitive reviews, expansion of clinical trial infrastructure in collaboration with New Jersey Department of Health, and philanthropic commitments from regional foundations and corporations. Over decades the center has absorbed programs in basic science from departments such as Department of Cell Biology and Neuroscience (Rutgers) and clinical programs from institutions like Saint Peter's University Hospital, while aligning with statewide cancer control plans driven by the American Cancer Society and regional coalitions.

Organization and Leadership

Administrative structure spans academic leadership in concert with hospital executive teams and external advisory boards featuring leaders from institutions including Rutgers Cancer Institute of New Jersey-affiliated clinicians, academic deans from Rutgers School of Public Health, and investigators with appointments at RWJBarnabas Health. Leadership roles have been held by physician-scientists and administrators who previously served at organizations such as Memorial Sloan Kettering Cancer Center, Dana–Farber Cancer Institute, and Johns Hopkins Medicine, reflecting cross-institutional recruitment. Governance includes program directors for areas like immuno-oncology, translational therapeutics, and cancer epidemiology, in addition to cores managed by directors with prior service at Fred Hutchinson Cancer Research Center and Moffitt Cancer Center. External advisory committees draw members from entities such as American Association for Cancer Research and National Institutes of Health-affiliated investigators to guide strategic priorities.

Facilities and Locations

Facilities are distributed across Rutgers campuses and affiliated hospitals including sites in New Brunswick, New Jersey, Newark, New Jersey, and Piscataway, New Jersey. Core laboratory space is located in research buildings proximate to Rutgers University–New Brunswick campuses and clinical facilities on hospital campuses historically affiliated with RWJBarnabas Health and Hackensack Meridian Health partners. Specialized environments include Good Manufacturing Practice facilities for cellular therapy development modeled after units at Mayo Clinic and sequencing cores with instrumentation comparable to those at Broad Institute. Diagnostic and imaging suites house technologies such as PET/CT scanners and MR systems used in clinical trials comparable to platforms at Cleveland Clinic. Collaborative incubators and biobanks link to regional resources including the New Jersey Biobank and statewide data systems.

Research Programs and Centers

Major research programs emphasize basic cancer biology, immunotherapy, precision oncology, cancer prevention, and population science. Investigative teams study oncogenic signaling pathways with connections to seminal work from groups at Cold Spring Harbor Laboratory and gene-editing efforts influenced by methodologies from Broad Institute and Harvard Medical School. Immuno-oncology programs evaluate tumor microenvironment and adoptive cell therapies informed by advances at National Cancer Institute laboratories and programs at University of Pennsylvania (CAR T-cell models). Precision medicine initiatives leverage genomic profiling pipelines similar to those pioneered at Memorial Sloan Kettering Cancer Center and integrate epidemiologic cohorts modeled after studies at Framingham Heart Study-like longitudinal efforts and collaborations with Centers for Disease Control and Prevention surveillance. Translational centers focus on drug discovery, early-phase trials, and biomarker development with partnerships echoing consortia such as Stand Up To Cancer and cooperative group trials under SWOG. Population and disparities research engages communities in studies shaped by frameworks from National Institute on Minority Health and Health Disparities.

Clinical Services and Patient Care

Clinical care encompasses multidisciplinary oncology services including medical oncology, surgical oncology, radiation oncology, hematology, and supportive care across affiliated hospitals and outpatient clinics. Cancer care delivery uses tumor boards and molecular tumor profiling informed by models at MD Anderson Cancer Center and shared-decision tools akin to those developed at Mayo Clinic. Clinical trials infrastructure supports phase I–III studies in collaboration with cooperative groups such as Alliance for Clinical Trials in Oncology and industry partners, and integrates palliative care and survivorship programs inspired by standards from Institute of Medicine reports. Patient navigation and psychosocial services coordinate with community oncology practices and patient advocacy organizations like Susan G. Komen to address access and continuity of care.

Education, Training, and Community Outreach

Education programs include fellowship training in oncology disciplines, research training fellowships, and graduate courses for students enrolled at Rutgers Robert Wood Johnson Medical School and Rutgers School of Biomedical Sciences. Trainee mentorship involves faculty with experience from institutions such as Yale School of Medicine and Columbia University Irving Medical Center. Community outreach targets cancer prevention, screening initiatives, and risk-reduction campaigns in partnership with organizations such as American Cancer Society and county health departments, and conducts public education modeled after programs by Centers for Disease Control and Prevention. Efforts to reduce disparities include mobile screening vans, community health worker programs, and collaborations with local nonprofits and faith-based organizations to increase participation in prevention and clinical research.

Category:Medical research institutes in New Jersey